Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Interventional × dapagliflozin × Clear all

Phase

Phase 2 7 Phase 3 5 Phase 1 4 Phase 4 2 Phase NA 1 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1

Interventions

Cisplatin 81 Fluorouracil 55 Gemcitabine 53 Docetaxel 52 Paclitaxel 51 Oxaliplatin 51 Carboplatin 50 Cyclophosphamide 49 Capecitabine 49 Radiotherapy 42 Drug Therapy 42 pembrolizumab 33 Leucovorin 31 Bevacizumab 31 Doxorubicin 28 Dexamethasone 25 Magnetic Resonance Spectroscopy 24 Cytarabine 23 Nivolumab 22 Etoposide 22 Pemetrexed 21 Methotrexate 21 Radiation 16 apatinib 15 Vincristine 15 Prednisone 15 Epirubicin 15 venetoclax 14 Trastuzumab 14 Temozolomide 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07033585 2025-07-11

GD-T2D

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

Diabetes Mellitus, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡